{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:06:19Z","timestamp":1762905979335,"version":"3.45.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002283","name":"Alzheimer's Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Aging Brain"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.nbas.2022.100062","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T13:50:46Z","timestamp":1672235446000},"page":"100062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Age-related reduction in brain ACE-2 is not exacerbated by Alzheimer\u2019s disease pathology in mouse models of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"3","author":[{"given":"Robert","family":"MacLachlan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siew Yeen","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Good","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick Gavin","family":"Kehoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Scott","family":"Miners","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nbas.2022.100062_b0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11906-019-1011-2","article-title":"The renin-angiotensin system in the central nervous system and its role in blood pressure regulation","volume":"22","author":"Nakagawa","year":"2020","journal-title":"Curr Hypertens Rep"},{"issue":"7","key":"10.1016\/j.nbas.2022.100062_b0010","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1161\/ATVBAHA.118.311282","article-title":"Renin-angiotensin system and cardiovascular functions","volume":"38","author":"Wu","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.nbas.2022.100062_b0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin\u2013angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.nbas.2022.100062_b0020","doi-asserted-by":"crossref","unstructured":"Almutlaq M, Alamro AA, Alamri HS, Alghamdi AA, Barhoumi T. The effect of local renin angiotensin system in the common types of cancer. 2021;12.","DOI":"10.3389\/fendo.2021.736361"},{"issue":"1","key":"10.1016\/j.nbas.2022.100062_b0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13195-016-0217-7","article-title":"Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-beta and tau pathology","volume":"8","author":"Kehoe","year":"2016","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.nbas.2022.100062_b0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3233\/JAD-161265","article-title":"Angiotensin-III is increased in Alzheimer's disease in association with amyloid-beta and Tau pathology","volume":"58","author":"Kehoe","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.nbas.2022.100062_b0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2990.2007.00885.x","article-title":"Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy","volume":"34","author":"Miners","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"10.1016\/j.nbas.2022.100062_b0040","first-page":"163","article-title":"Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes","volume":"1","author":"Miners","year":"2009","journal-title":"Am J Transl Res"},{"issue":"3","key":"10.1016\/j.nbas.2022.100062_b0045","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.sjbs.2020.01.026","article-title":"Role of brain renin angiotensin system in neurodegeneration: An update","volume":"27","author":"Abiodun","year":"2020","journal-title":"Saudi J Biol Sci"},{"issue":"20","key":"10.1016\/j.nbas.2022.100062_b0050","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1016\/j.febslet.2012.09.004","article-title":"Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains","volume":"586","author":"Tian","year":"2012","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.nbas.2022.100062_b0055","doi-asserted-by":"crossref","first-page":"e16037","DOI":"10.1371\/journal.pone.0016037","article-title":"Central angiotensin II stimulation promotes beta amyloid production in Sprague Dawley rats","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbas.2022.100062_b0060","first-page":"113","article-title":"Clinical relevance of LOCAL Renin Angiotensin Systems","volume":"14","author":"Campbell","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.nbas.2022.100062_b0065","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41440-020-0396-2","article-title":"A colorful view of the brain renin\u2013angiotensin system","volume":"43","author":"Sigmund","year":"2020","journal-title":"Hypertens Res"},{"issue":"4","key":"10.1016\/j.nbas.2022.100062_b0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11906-019-0937-8","article-title":"Revisiting the brain renin-angiotensin system-focus on novel therapies","volume":"21","author":"Ren","year":"2019","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"10.1016\/j.nbas.2022.100062_b0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/1044-7431(91)90035-M","article-title":"Neuronal angiotensin-converting enzyme (ACE) gene expression is increased by converting enzyme inhibitors (CEI)","volume":"2","author":"King","year":"1991","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.nbas.2022.100062_b0080","doi-asserted-by":"crossref","unstructured":"Simoes e Silva AC, Silveira KD, Ferreira AJ, Teixeira MM. ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol. 2013;169(3):477-92.","DOI":"10.1111\/bph.12159"},{"issue":"3","key":"10.1016\/j.nbas.2022.100062_b0085","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mcn.2005.03.012","article-title":"Angiotensin-(1\u20137) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas","volume":"29","author":"Hellner","year":"2005","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.nbas.2022.100062_b0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2010.07.006","article-title":"Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease","volume":"1352","author":"Yamada","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.nbas.2022.100062_b0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pnpbp.2012.12.009","article-title":"Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus","volume":"43","author":"Bild","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.nbas.2022.100062_b0100","doi-asserted-by":"crossref","unstructured":"Takeda S, Sato N, Rakugi H, Morishita R. P2-364: Improvement of cognitive decline and cerebrovascular dysfunction in a mouse model of Alzheimer's disease by the angiotensin receptor blocker, olmesartan. 2008;4(4S_Part_14):T479-T.","DOI":"10.1016\/j.jalz.2008.05.1442"},{"issue":"3","key":"10.1016\/j.nbas.2022.100062_b0105","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3233\/JAD-171119","article-title":"The coming of age of the angiotensin hypothesis in Alzheimer's disease: progress toward disease prevention and treatment?","volume":"62","author":"Kehoe","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.nbas.2022.100062_b0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/alzrt3","article-title":"Angiotensins and Alzheimer's disease: a bench to bedside overview","volume":"1","author":"Kehoe","year":"2009","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"10.1016\/j.nbas.2022.100062_b0115","doi-asserted-by":"crossref","first-page":"e2012252","DOI":"10.1001\/jamanetworkopen.2020.12252","article-title":"Effects of candesartan vs lisinopril on neurocognitive function in older adults with executive mild cognitive impairment: A randomized clinical trial","volume":"3","author":"Hajjar","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.nbas.2022.100062_b0120","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1474-4422(21)00263-5","article-title":"Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"20","author":"Kehoe","year":"2021","journal-title":"Lancet Neurol"},{"issue":"3 Pt 2","key":"10.1016\/j.nbas.2022.100062_b0125","first-page":"R450","article-title":"Renin-angiotensin system, converting-enzyme inhibition and kidney function in aging female rats","volume":"251","author":"Corman","year":"1986","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1016\/j.nbas.2022.100062_b0130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1210\/jcem-62-2-384","article-title":"Effect of age on the renin-angiotensin-aldosterone system in normal subjects: simultaneous measurement of active and inactive renin, renin substrate, and aldosterone in plasma","volume":"62","author":"Tsunoda","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.nbas.2022.100062_b0135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ki.1975.120","article-title":"Effect on aging on plasma renin and aldosterone in normal man","volume":"8","author":"Weidmann","year":"1975","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.nbas.2022.100062_b0140","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/archinte.1977.03630220056014","article-title":"Age and the renin-aldosterone system","volume":"137","author":"Noth","year":"1977","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nbas.2022.100062_b0145","doi-asserted-by":"crossref","first-page":"6731093","DOI":"10.1155\/2016\/6731093","article-title":"Age-associated changes in the vascular renin-angiotensin system in mice","volume":"2016","author":"Yoon","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.nbas.2022.100062_b0150","doi-asserted-by":"crossref","unstructured":"Burks TN, Marx R, Powell L, Rucker J, Bedja D, Heacock E, et al. Combined effects of aging and inflammation on renin-angiotensin system mediate mitochondrial dysfunction and phenotypic changes in cardiomyopathies. Oncotarget; Vol 6, No 14. 2015.","DOI":"10.18632\/oncotarget.3979"},{"issue":"3","key":"10.1016\/j.nbas.2022.100062_b0155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2217\/14796678.4.3.237","article-title":"Aging and the brain renin-angiotensin system: relevance to age-related decline in cardiac function","volume":"4","author":"Diz","year":"2008","journal-title":"Future Cardiol"},{"issue":"40","key":"10.1016\/j.nbas.2022.100062_b0160","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J Neurosci"},{"issue":"6514","key":"10.1016\/j.nbas.2022.100062_b0165","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","article-title":"Alzheimer-type neuropathology in transgenic mice overexpressing V717F \u03b2-amyloid precursor protein","volume":"373","author":"Games","year":"1995","journal-title":"Nature"},{"issue":"5284","key":"10.1016\/j.nbas.2022.100062_b0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.nbas.2022.100062_b0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1050-3862(96)00167-2","article-title":"A vector for expressing foreign genes in the brains and hearts of transgenic mice","volume":"13","author":"Borchelt","year":"1996","journal-title":"Genetic Anal: Biomol Eng"},{"issue":"3","key":"10.1016\/j.nbas.2022.100062_b0180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00401-019-02098-6","article-title":"ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"139","author":"Evans","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.nbas.2022.100062_b0185","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-190721","article-title":"Cerebrospinal fluid changes in the renin-angiotensin system in Alzheimer's disease","volume":"72","author":"Kehoe","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nbas.2022.100062_b0190","doi-asserted-by":"crossref","unstructured":"MacLachlan R, Kehoe PG, Miners JS. Dysregulation of ACE-1 in normal aging and the early stages of Alzheimer's disease. J Gerontol Ser A, Biol Sci Med Sci 2022.","DOI":"10.1093\/gerona\/glac083"},{"issue":"2","key":"10.1016\/j.nbas.2022.100062_b0195","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.RES.72.2.312","article-title":"Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II","volume":"72","author":"Schunkert","year":"1993","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.nbas.2022.100062_b0200","doi-asserted-by":"crossref","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","article-title":"Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?","volume":"310","author":"Chappell","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.nbas.2022.100062_b0205","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neurobiolaging.2006.10.010","article-title":"Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels","volume":"29","author":"Hellstr\u00f6m-Lindahl","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nbas.2022.100062_b0210","doi-asserted-by":"crossref","unstructured":"El-Arif G, Farhat A, Khazaal S, Annweiler C, Kovacic H, Wu Y, et al. The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19. Molecules (Basel, Switzerland). 2021;26(22).","DOI":"10.3390\/molecules26226945"},{"issue":"10","key":"10.1016\/j.nbas.2022.100062_b0215","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1093\/brain\/awaa240","article-title":"The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings","volume":"143","author":"Paterson","year":"2020","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.nbas.2022.100062_b0220","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/alz.12255","article-title":"The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning","volume":"17","author":"de Erausquin","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.nbas.2022.100062_b0225","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","article-title":"6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"23","key":"10.1016\/j.nbas.2022.100062_b0230","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic features in severe SARS-CoV-2 infection","volume":"382","author":"Helms","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.nbas.2022.100062_b0235","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","article-title":"Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19","volume":"24","author":"Meinhardt","year":"2021","journal-title":"Nat Neurosci"},{"issue":"11","key":"10.1016\/j.nbas.2022.100062_b0240","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","article-title":"Neuropathology of patients with COVID-19 in Germany: a post-mortem case series","volume":"19","author":"Matschke","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nbas.2022.100062_b0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-04569-5","article-title":"SARS-CoV-2 is associated with changes in brain structure in UK Biobank","author":"Douaud","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.nbas.2022.100062_b0250","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.stemcr.2022.03.016","article-title":"The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research","volume":"17","author":"Muhl","year":"2022","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.nbas.2022.100062_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113837","article-title":"ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations","volume":"345","author":"Hern\u00e1ndez","year":"2021","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.nbas.2022.100062_b0260","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12987-022-00339-7","article-title":"Potential role of astrocyte angiotensin converting enzyme 2 in the neural transmission of COVID-19 and a neuroinflammatory state induced by smoking and vaping","volume":"19","author":"Zhang","year":"2022","journal-title":"Fluids and Barriers of the CNS"},{"issue":"21","key":"10.1016\/j.nbas.2022.100062_b0265","doi-asserted-by":"crossref","first-page":"11622","DOI":"10.3390\/ijms222111622","article-title":"Infection of brain pericytes underlying neuropathology of COVID-19 patients","volume":"22","author":"Bocci","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nbas.2022.100062_b0270","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fnmol.2017.00427","article-title":"Involvement of astrocytes in Alzheimer's disease from a neuroinflammatory and oxidative stress perspective","volume":"10","author":"Gonzalez-Reyes","year":"2017","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.nbas.2022.100062_b0275","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2011.07.001","article-title":"Brain renin-angiotensin\u2013a new look at an old system","volume":"95","author":"Wright","year":"2011","journal-title":"Prog Neurobiol"},{"issue":"3","key":"10.1016\/j.nbas.2022.100062_b0280","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3390\/ijms19030876","article-title":"Within the brain: the renin angiotensin system","volume":"19","author":"Jackson","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.nbas.2022.100062_b0285","first-page":"266","article-title":"Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease","volume":"1","author":"O'Hagan","year":"2012","journal-title":"Am J Neurodegener Dis"}],"container-title":["Aging Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589958922000342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589958922000342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:03:36Z","timestamp":1762905816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589958922000342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":57,"alternative-id":["S2589958922000342"],"URL":"https:\/\/doi.org\/10.1016\/j.nbas.2022.100062","relation":{},"ISSN":["2589-9589"],"issn-type":[{"type":"print","value":"2589-9589"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age-related reduction in brain ACE-2 is not exacerbated by Alzheimer\u2019s disease pathology in mouse models of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Aging Brain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbas.2022.100062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100062"}}